GPR18, a cannabinoid-stimulated G protein-coupled receptor, has been implicated in a variety of cancers, involving melanoma 34, breast cancer 35, oral cancer 36, and hepatocellular carcinoma 37. Here, GPR18 is linked to breast carcinoma.